
NYSEHealthcareDrug Manufacturers - Specialty & Generic
最新データ
$15.06
+$0.56 · +3.86%
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
前日終値
$15.06
+$0.56 · +3.86%
日中の時刻はETです。市場データは遅延する場合があります。
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
日中レンジ
現在 $15.06
52週レンジ
現在 $15.06
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
65
割安
センチメント
56
まちまち
リスク
58
やや高いリスク
モメンタム
26
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
日中レンジ
現在 $15.06
52週レンジ
現在 $15.06
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 42.53億 USD | 43.73億 USD | 46.56億 USD | 44.52億 USD | 41.39億 USD |
| 売上原価 | 27.59億 USD | 28.31億 USD | 29.75億 USD | 29.96億 USD | 27.23億 USD |
| 粗利益 | 14.95億 USD | 15.43億 USD | 16.8億 USD | 14.55億 USD | 14.16億 USD |
| 研究開発 | 9540万 USD | 1.12億 USD | 1.23億 USD | 1.23億 USD | 1.22億 USD |
| 販売・一般管理 | 5.27億 USD | 11.13億 USD | 12.75億 USD | 12.1億 USD | 11.11億 USD |
| 営業費用 | 11.51億 USD | 14.3億 USD | 15.29億 USD | 13.77億 USD | 10.06億 USD |
| 支払利息 | 1.63億 USD | 1.88億 USD | 1.74億 USD | 1.56億 USD | 1.25億 USD |
| 減価償却費と償却費 | 3.38億 USD | 3.26億 USD | 3.6億 USD | 3.39億 USD | 3.12億 USD |
| 営業利益 | 3.43億 USD | 1.13億 USD | 1.52億 USD | 7890万 USD | 4.1億 USD |
| 純利益 | −14.25億 USD | −1.72億 USD | −1270万 USD | −1.41億 USD | −6890万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$36.20
上昇余地(140.37%)価格履歴は利用できません
最高:$54.00平均:$36.20最低:$20.00分割調整後の1株当たりの年間現金分配金。
$1.16
2025年(通年)+20.8% 以来 2021
2026年(一部):$0.87
$0.96
2,021
$1.04
2,022
$1.092
2,023
$1.104
2,024
$1.16
2,025
$0.87
2,026*
* 利用可能な配当履歴のうち、暦年の一部のみを含みます。
| 種別 | 配当落ち日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
配当 | 2026年8月28日 | $0.29Quarterly | 2026年8月28日 | 2026年9月15日 |
配当 | 2026年5月29日 | $0.29Quarterly | 2026年5月29日 | 2026年6月16日 |
配当 | 2026年3月2日 | $0.29Quarterly | 2026年3月2日 | 2026年3月24日 |
配当 | 2025年11月28日 | $0.29Quarterly | 2025年11月28日 | 2025年12月16日 |
配当 | 2025年8月29日 | $0.29Quarterly | 2025年8月29日 | 2025年9月16日 |
配当 | 2025年5月30日 | $0.29Quarterly | 2025年5月30日 | 2025年6月17日 |
配当落ち 2026年8月28日
$0.29
Quarterly
2026年8月28日基準 · 支払日 2026年9月15日
配当落ち 2026年5月29日
$0.29
Quarterly
2026年5月29日基準 · 支払日 2026年6月16日
配当落ち 2026年3月2日
$0.29
Quarterly
2026年3月2日基準 · 支払日 2026年3月24日
配当落ち 2025年11月28日
$0.29
Quarterly
2025年11月28日基準 · 支払日 2025年12月16日
配当落ち 2025年8月29日
$0.29
Quarterly
2025年8月29日基準 · 支払日 2025年9月16日
配当落ち 2025年5月30日
$0.29
Quarterly
2025年5月30日基準 · 支払日 2025年6月17日
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。